$NRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NephroGenex, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NephroGenex, Inc.. Get notifications about new insider transactions in NephroGenex, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10 2015 | NRX | NephroGenex, Inc. | Steiner Eugen | Director | Grant | A | 0.00 | 76,045 | 0 | 76,045 | 0 to 76 K |
| Nov 12 2015 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Grant | A | 0.00 | 646,930 | 0 | 659,430 | 12.5 K to 659.4 K (+5,175.44 %) |
| Nov 12 2015 | NRX | NephroGenex, Inc. | Hamill John | Chief Financial Off ... | Grant | A | 0.00 | 136,381 | 0 | 136,381 | 0 to 136.4 K |
| Nov 12 2015 | NRX | NephroGenex, Inc. | Patel Jaikrishna | Chief Medical Offic ... | Grant | A | 0.00 | 97,306 | 0 | 97,306 | 0 to 97.3 K |
| Aug 07 2015 | NRX | NephroGenex, Inc. | Patel Jaikrishna | Chief Medical Offic ... | Option Exercise | A | 4.12 | 54,347 | 223,910 | 54,347 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Fox J. Wesley | Pres. & Chief Sci. ... | Option Exercise | A | 7.31 | 15,000 | 109,650 | 15,000 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Taglietti Marco | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Steiner Eugen | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Peterson Bob | VP of Prod. Dev. & ... | Option Exercise | A | 7.31 | 11,500 | 84,065 | 11,500 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Mitchum James P. | Director | Option Exercise | A | 7.31 | 13,740 | 100,439 | 13,740 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Option Exercise | A | 7.31 | 6,870 | 50,220 | 6,870 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 7.31 | 50,000 | 365,500 | 50,000 | |
| May 04 2015 | NRX | NephroGenex, Inc. | Hamill John | Chief Financial Off ... | Option Exercise | A | 7.31 | 15,000 | 109,650 | 15,000 | |
| Jan 06 2015 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | 10% Owner | Sell | S | 9.90 | 20,941 | 207,339 | 1,052,966 | 1.1 M to 1.1 M (-1.95 %) |
| Jan 06 2015 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | 10% Owner | Sell | S | 10.54 | 164,919 | 1,738,065 | 1,073,907 | 1.2 M to 1.1 M (-13.31 %) |
| Jan 06 2015 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | 10% Owner | Sell | S | 10.83 | 88,000 | 953,207 | 1,238,826 | 1.3 M to 1.2 M (-6.63 %) |
| Dec 15 2014 | NRX | NephroGenex, Inc. | Peterson Bob | VP of Prod. Dev. & ... | Option Exercise | A | 4.67 | 33,500 | 156,445 | 33,500 | |
| Dec 15 2014 | NRX | NephroGenex, Inc. | Fox J. Wesley | Pres. & Chief Sci. ... | Option Exercise | A | 4.67 | 45,000 | 210,150 | 45,000 | |
| Dec 15 2014 | NRX | NephroGenex, Inc. | Hamill John | Chief Financial Off ... | Option Exercise | A | 4.67 | 45,000 | 210,150 | 45,000 | |
| Dec 15 2014 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 4.67 | 150,000 | 700,500 | 150,000 | |
| Nov 25 2014 | NRX | NephroGenex, Inc. | Peterson Bob | VP of Prod. Dev. & ... | Buy | P | 4.20 | 2,000 | 8,400 | 2,000 | 0 to 2 K |
| Oct 02 2014 | NRX | NephroGenex, Inc. | Taglietti Marco | Director | Option Exercise | A | 4.49 | 22,656 | 101,725 | 22,656 | |
| Aug 15 2014 | NRX | NephroGenex, Inc. | Fox J. Wesley | Pres. & Chief Sci. ... | Option Exercise | A | 4.49 | 28,000 | 125,720 | 28,000 | |
| Aug 15 2014 | NRX | NephroGenex, Inc. | Hamill John | Chief Financial Off ... | Option Exercise | A | 4.49 | 24,000 | 107,760 | 24,000 | |
| Aug 15 2014 | NRX | NephroGenex, Inc. | Peterson Bob | VP of Prod. Dev. & ... | Option Exercise | A | 4.49 | 21,000 | 94,290 | 21,000 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Steiner Eugen | Director | Option Exercise | A | 11.90 | 3,076 | 36,604 | 3,076 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Hamill John | Chief Financial Off ... | Option Exercise | A | 11.90 | 30,769 | 366,151 | 30,769 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Option Exercise | A | 11.90 | 3,076 | 36,604 | 3,076 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Option Exercise | A | 11.90 | 3,076 | 36,604 | 3,076 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Peterson Bob | VP of Prod. Dev. & ... | Option Exercise | A | 11.90 | 11,538 | 137,302 | 11,538 | |
| May 16 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | A | 11.90 | 3,076 | 36,604 | 3,076 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Mitchum James P. | Director | Option Exercise | A | 11.90 | 3,076 | 36,604 | 3,076 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 2.02 | 12,343 | 24,933 | 12,343 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 2.02 | 24,686 | 49,866 | 24,686 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 12.00 | 38,078 | 456,936 | 38,078 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 12.00 | 76,156 | 913,872 | 76,156 | |
| May 16 2014 | NRX | NephroGenex, Inc. | Fox J. Wesley | Pres. & Chief Sci. ... | Option Exercise | A | 11.90 | 15,384 | 183,070 | 15,384 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 106,697 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 1,215,268 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 494,447 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Option Exercise | C | 0.00 | 5,631,531 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Grant | A | 0.00 | 180,997 | 0 | 1,326,826 | 1.1 M to 1.3 M (+15.80 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Buy | C | 0.00 | 203,374 | 0 | 1,145,829 | 942.5 K to 1.1 M (+21.58 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | VOGELBAUM MARTIN | Director | Buy | C | 0.00 | 942,455 | 0 | 942,455 | 0 to 942.5 K |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Option Exercise | C | 0.00 | 5,785,962 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Option Exercise | C | 0.00 | 5,785,962 | 0 | 5,785,962 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Option Exercise | C | 0.00 | 13,964,398 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Buy | P | 12.00 | 790,000 | 9,480,000 | 4,241,097 | 3.5 M to 4.2 M (+22.89 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Grant | A | 0.00 | 412,592 | 0 | 3,451,097 | 3 M to 3.5 M (+13.58 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Buy | C | 0.00 | 890,140 | 0 | 3,038,505 | 2.1 M to 3 M (+41.43 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Seltzer Robert R. | Director | Buy | C | 0.00 | 2,148,365 | 0 | 2,148,365 | 0 to 2.1 M |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Option Exercise | C | 0.00 | 5,785,962 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Option Exercise | C | 0.00 | 5,785,962 | 0 | 5,785,962 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Option Exercise | C | 0.00 | 13,964,398 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Buy | P | 12.00 | 790,000 | 9,480,000 | 4,241,097 | 3.5 M to 4.2 M (+22.89 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Grant | A | 0.00 | 412,592 | 0 | 3,451,097 | 3 M to 3.5 M (+13.58 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Buy | C | 0.00 | 890,140 | 0 | 3,038,505 | 2.1 M to 3 M (+41.43 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Markham Richard J | Director | Buy | C | 0.00 | 2,148,365 | 0 | 2,148,365 | 0 to 2.1 M |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 106,697 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 1,215,268 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 106,697 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 1,215,268 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 494,447 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Option Exercise | C | 0.00 | 5,631,531 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Grant | A | 0.00 | 180,997 | 0 | 1,326,826 | 1.1 M to 1.3 M (+15.80 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Buy | C | 0.00 | 203,374 | 0 | 1,145,829 | 942.5 K to 1.1 M (+21.58 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Rho Ventures V, L.P. | Director | Buy | C | 0.00 | 942,455 | 0 | 942,455 | 0 to 942.5 K |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Care Capital III LLC | Director | Option Exercise | C | 0.00 | 5,781,269 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Care Capital III LLC | Director | Option Exercise | C | 0.00 | 5,785,962 | 0 | 5,785,962 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Care Capital III LLC | Director | Option Exercise | C | 0.00 | 13,964,398 | 0 | 0 | |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Care Capital III LLC | Director | Buy | P | 12.00 | 790,000 | 9,480,000 | 4,241,097 | 3.5 M to 4.2 M (+22.89 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Care Capital III LLC | Director | Grant | A | 0.00 | 412,592 | 0 | 3,451,097 | 3 M to 3.5 M (+13.58 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Care Capital III LLC | Director | Buy | C | 0.00 | 890,140 | 0 | 3,038,505 | 2.1 M to 3 M (+41.43 %) |
| Feb 19 2014 | NRX | NephroGenex, Inc. | Care Capital III LLC | Director | Buy | C | 0.00 | 2,148,365 | 0 | 2,148,365 | 0 to 2.1 M |
Page: 1